Rapid screening of EGFR mutations in patients with non-small cell lung cancer, breast cancer and head and neck cancer treated with gefitinib on a compassionate-use program

被引：0
|
作者：
Murray, S
Razis, E
Linardou, H
Lambropoulos, S
Briasoulis, E
Skarlos, D
Pectasides, D
Kalofonos, HP
Papadimitriou, C
Kosmidis, P
Fountzilas, G
机构：
[1] Metropolitan Hosp, Athens, Greece
[2] HYGEIA Med Ctr, Athens, Greece
[3] Ioannina Univ Hosp, Ioannina, Greece
[4] Attikon Univ Hosp, Athens, Greece
[5] Alexandra Univ Hosp, Patras, Greece
[6] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece
[7] Henry Dunan Med Ctr, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [41] Frequency and types of EGFR mutations in Moroccan patients with non-small cell lung cancer
    Sow, Mohamed Lemine
    El Yacoubi, Hind
    Moukafih, Badreddine
    Balde, Salif
    Akimana, Gloria
    Najem, Salma
    El Khoyaali, Siham
    Abahssain, Halima
    Chaibi, Aicha
    Khan, Shah Zeb
    Trapani, Dario
    Benzekri, Asmae
    Ghaouti, Merieme
    Gamra, Lamia
    Mestari, Amina
    Kettani, Fouad
    Rahali, Younes
    Mrabti, Hind
    Elghissassi, Ibrahim
    Errihani, Hassan
    TUMORI JOURNAL, 2021, 107 (04): : 335 - 340
  • [42] Gefitinib therapy for non-small cell lung cancer
    Birnbaum A.
    Ready N.
    Current Treatment Options in Oncology, 2005, 6 (1) : 75 - 81
  • [43] Treatment of non-small-cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use programme
    Razis, Evangelia
    Skarlos, Dimosthenis V.
    Briassoulis, Evangelos
    Dimopoulos, Meletios
    Fountzilas, George
    Lambropoulos, Stefanos
    Rigatos, Sotiris
    Kopteridis, P.
    Efstathiou, Helen
    Kosmidis, Paris
    ANNALS OF ONCOLOGY, 2004, 15 : 183 - 183
  • [44] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [45] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
  • [46] Zoledronic acid increases the antitumor effect of gefitinib treatment for non-small cell lung cancer with EGFR mutations
    Feng, Chengjun
    Liu, Xiaoke
    Li, Xiaoyu
    Guo, Fuchun
    Huang, Chuying
    Qin, Qing
    Wang, Yongsheng
    ONCOLOGY REPORTS, 2016, 35 (06) : 3460 - 3470
  • [47] Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non-Small Cell Lung Cancer with EGFR Mutations
    Morita, Satoshi
    Okamoto, Isamu
    Kobayashi, Kunihiko
    Yamazaki, Koichi
    Asahina, Hajime
    Inoue, Akira
    Hagiwara, Koichi
    Sunaga, Noriaki
    Yanagitani, Noriko
    Hida, Toyoaki
    Yoshida, Kimihide
    Hirashima, Tomonori
    Yasumoto, Kosei
    Sugio, Kenji
    Mitsudomi, Tetsuya
    Fukuoka, Masahiro
    Nukiwa, Toshihiro
    CLINICAL CANCER RESEARCH, 2009, 15 (13) : 4493 - 4498
  • [48] The presence of EGFR mutations predicts the response in Chinese non-small cell lung cancer patients treated with erlotinib
    Li, Rui-chao
    Zheng, Li-jun
    Fang, Ming-hao
    Yu, Shi-ying
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (02): : E112 - E119
  • [49] Clinical Significance of Erlotinib Monotherapy for Gefitinib-resistant Non-small Cell Lung Cancer with EGFR Mutations
    Koyama, Nobuyuki
    Uchida, Yoshitaka
    ANTICANCER RESEARCH, 2013, 33 (11) : 5083 - 5089
  • [50] Recurrence patterns of advanced non-small cell lung cancer treated with gefitinib
    Chen Min-jiang
    Zhong Wei
    Zhang Li
    Zhao Jing
    Li Long-yun
    Wang Meng-zhao
    CHINESE MEDICAL JOURNAL, 2013, 126 (12) : 2235 - 2241
12345